← FDA Drug Approvals (Drugs@FDA)

TABRECTA

NDA · New Drug Application · Sponsor: NOVARTIS PHARM · Approved 2020-05-06

Drug application

FDA Application #

NDA213591

Application type

New Drug Application

Brand name

TABRECTA

Generic name

CAPMATINIB

Active ingredients

CAPMATINIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS PHARM

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2020-05-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown